Stoke Therapeutics Statistics Share Statistics Stoke Therapeutics has 54.6M
shares outstanding. The number of shares has increased by 3.7%
in one year.
Shares Outstanding 54.6M Shares Change (YoY) 3.7% Shares Change (QoQ) 3.08% Owned by Institutions (%) 97.61% Shares Floating 45.86M Failed to Deliver (FTD) Shares 4,164 FTD / Avg. Volume 0.64%
Short Selling Information The latest short interest is 11.5M, so 21.06% of the outstanding
shares have been sold short.
Short Interest 11.5M Short % of Shares Out 21.06% Short % of Float 25.48% Short Ratio (days to cover) 23.53
Valuation Ratios The PE ratio is -6.69 and the forward
PE ratio is -4.55.
Stoke Therapeutics's PEG ratio is
0.22.
PE Ratio -6.69 Forward PE -4.55 PS Ratio 16.3 Forward PS 29 PB Ratio 2.6 P/FCF Ratio -6.84 PEG Ratio 0.22
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Stoke Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.81,
with a Debt / Equity ratio of 0.01.
Current Ratio 5.81 Quick Ratio 5.81 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $285.59K Profits Per Employee $-695.16K Employee Count 128 Asset Turnover 0.13 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -9.07% in the
last 52 weeks. The beta is 1.15, so Stoke Therapeutics's
price volatility has been higher than the market average.
Beta 1.15 52-Week Price Change -9.07% 50-Day Moving Average 11.97 200-Day Moving Average 10.57 Relative Strength Index (RSI) 56.53 Average Volume (20 Days) 647,025
Income Statement In the last 12 months, Stoke Therapeutics had revenue of 36.55M
and earned -88.98M
in profits. Earnings per share was -1.65.
Revenue 36.55M Gross Profit 32.11M Operating Income -101.37M Net Income -88.98M EBITDA -99.19M EBIT -101.37M Earnings Per Share (EPS) -1.65
Full Income Statement Balance Sheet The company has 127.98M in cash and 2.32M in
debt, giving a net cash position of 125.66M.
Cash & Cash Equivalents 127.98M Total Debt 2.32M Net Cash 125.66M Retained Earnings -490.83M Total Assets 406.89M Working Capital 331.05M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -86.85M
and capital expenditures -203K, giving a free cash flow of -87.05M.
Operating Cash Flow -86.85M Capital Expenditures -203K Free Cash Flow -87.05M FCF Per Share -1.61
Full Cash Flow Statement Margins Gross margin is 87.85%, with operating and profit margins of -277.31% and -243.42%.
Gross Margin 87.85% Operating Margin -277.31% Pretax Margin -243.42% Profit Margin -243.42% EBITDA Margin -271.36% EBIT Margin -277.31% FCF Margin -238.15%
